669080-86-8 Usage
General Description
5-[N-(3',5'-BISTRIFLUOROMETHYLBENZYL)AMINO]-2-METHYLTETRAZOLE is a chemical compound that belongs to the tetrazole class of organic compounds. It is characterized by the presence of a tetrazole ring, which is a five-membered ring containing four nitrogen atoms and one carbon atom. 5-[N-(3',5'-BISTRIFLUOROMETHYLBENZYL)AMINO]-2-METHYLTETRAZOLE also contains an amino group attached to a benzyl group, which in turn is substituted with a trifluoromethyl group. The presence of these functional groups gives 5-[N-(3',5'-BISTRIFLUOROMETHYLBENZYL)AMINO]-2-METHYLTETRAZOLE unique chemical properties and potential applications in medicinal chemistry, particularly in the development of pharmaceuticals and bioactive compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 669080-86-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,9,0,8 and 0 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 669080-86:
(8*6)+(7*6)+(6*9)+(5*0)+(4*8)+(3*0)+(2*8)+(1*6)=198
198 % 10 = 8
So 669080-86-8 is a valid CAS Registry Number.
669080-86-8Relevant articles and documents
Design, synthesis and biological evaluation of n,n-substituted amine derivatives as cholesteryl ester transfer protein inhibitors
Wang, Xinran,Hao, Lijuan,Xu, Xuanqi,Li, Wei,Liu, Chunchi,Zhao, Dongmei,Cheng, Maosheng
, (2017)
N,N-Substituted amine derivatives were designed by utilizing a bioisosterism strategy. Consequently, twenty-two compounds were synthesized and evaluated for their inhibitory activity against CETP. Structure-activity relationship (SAR) studies indicate tha
HETEROCYCLIC DERIVATIVES AS CETP INHIBITORS
-
Page/Page column 45-46, (2008/12/05)
The present invention provides a compound of formula (I), said compound is an inhibitor of CETP, and thus can be employed for the treatment of a disorder or disease mediated by CETP or responsive to the inhibition of CETP.
BICYCLIC DERIVATIVES AS CETP INHIBITORS
-
, (2008/06/13)
The present invention relates to novel compounds of formula (I): or a pharmaceutical composition thereof, with all the variables being defined in the text. The present invention further relates to the use of the compounds herein for treatment of or delay